Kestenberg-Messina Kaitlin M. sold ADMA

January 30, 2025 · Form 4 insider transaction

Kestenberg-Messina Kaitlin M. sold 3,355 shares of ADMA Biologics, Inc. at $16.10 per share, a transaction worth $54.0K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
3,355
Price
$16.10
Total value
$54.0K
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateJanuary 30, 2025
Filing dateFebruary 3, 2025
Shares owned after446,232
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements and payment by the Reporting Person of the option exercise price. This is not an open market sale of securities. This option was automatically exercised on the expiration date.; Includes, as of the transaction date (i) 192,320 unvested RSUs granted on April 1, 2024, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (ii) 22,500 unvested RSUs granted on July 24, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (iii) 71,250 unvested RSUs granted on March 6, 2023, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date;; (continued from footnote 2) (iv) 20,000 unvested RSUs granted on March 7, 2022, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; (v) 5,000 unvested RSUs granted on February 25, 2021, that will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date; and (vi) 135,162 shares of common stock owned by the reporting person, which reflects the option exercise described in footnote 1 and prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.

View the original Form 4 on SEC EDGAR